Differential Gene Expression and Tumorigenicity Analysis of Cultured Melanocyte Comparing Melanoma

Overview

Journal Int J Mol Cell Med

Date 2025 Feb 3

PMID 39895913

Authors

Atefeh Shahbazi

Seyed Jalal Zargar

Amir Bajouri

Parvaneh Mohammadi

Nasser Aghdami

Affiliations

Soon will be listed here.

Abstract

This study aimed to identify the optimal growth media for culturing human skin melanocytes for clinical applications and to assess their tumorigenic potential both and . Various growth media were tested to determine the most effective and safest for melanocyte culture, avoiding harmful growth factors such as TPA and colorant toxins. The study evaluated changes in RAF and gene expression through real-time PCR and gene sequencing of BRAF V600E and in exons 1 and 2, comparing these with melanoma. Melanocytes were subcutaneously injected into BALB/c nude mice to assess tumorigenic risk. Results indicated that a mixture of MGM-M2 supplemented with melanocyte growth factors provided the best outcomes in terms of cell proliferation and melanocyte count. Gene expression analysis revealed that HRAS and BRAF expressions in melanocytes at passage 6 showed less than 2-fold increases, whereas these genes were up-regulated by more than 3 and 8 folds, respectively, in melanoma cell lines. expression in melanocytes at passage 6 increased by 5-fold but remained lower than in melanoma cell lines. Gene sequencing of BRAF V600E and in exons 1 and 2 showed no mutations, and melanocytes injected into BALB/c nude mice exhibited no tumor formation risk. Furthermore, gene sequencing of and in the injected melanocytes 16 weeks' post-transplantation revealed no mutations. These findings suggest that while standard growth media protocols may elevate specific proto-oncogene expressions, they do not induce tumorigenic mutations in melanocytes, both and .

References

Bertolotto C . Melanoma: from melanocyte to genetic alterations and clinical options. Scientifica (Cairo). 2014; 2013:635203. PMC: 3874946. DOI: 10.1155/2013/635203. View

Czajkowski R . Comparison of melanocytes transplantation methods for the treatment of vitiligo. Dermatol Surg. 2004; 30(11):1400-5. DOI: 10.1111/j.1524-4725.2004.30435.x. View

Dumaz N, Hayward R, Martin J, Ogilvie L, Hedley D, Curtin J . In melanoma, RAS mutations are accompanied by switching signaling from BRAF to CRAF and disrupted cyclic AMP signaling. Cancer Res. 2006; 66(19):9483-91. DOI: 10.1158/0008-5472.CAN-05-4227. View

Lin S, Jee S, Hsiao W, Yu H, Tsai T, Chen J . Enhanced cell survival of melanocyte spheroids in serum starvation condition. Biomaterials. 2005; 27(8):1462-9. DOI: 10.1016/j.biomaterials.2005.08.031. View

Flockhart R, Webster D, Qu K, Mascarenhas N, Kovalski J, Kretz M . BRAFV600E remodels the melanocyte transcriptome and induces BANCR to regulate melanoma cell migration. Genome Res. 2012; 22(6):1006-14. PMC: 3371703. DOI: 10.1101/gr.140061.112. View

Orouji Z, Bajouri A, Ghasemi M, Mohammadi P, Fallah N, Shahbazi A . A single-arm open-label clinical trial of autologous epidermal cell transplantation for stable vitiligo: A 30-month follow-up. J Dermatol Sci. 2017; 89(1):52-59. DOI: 10.1016/j.jdermsci.2017.10.007. View

Seftor E, Brown K, Chin L, Kirschmann D, Wheaton W, Protopopov A . Epigenetic transdifferentiation of normal melanocytes by a metastatic melanoma microenvironment. Cancer Res. 2005; 65(22):10164-9. DOI: 10.1158/0008-5472.CAN-05-2497. View

Dessars B, De Raeve L, Morandini R, Lefort A, El Housni H, Ghanem G . Genotypic and gene expression studies in congenital melanocytic nevi: insight into initial steps of melanotumorigenesis. J Invest Dermatol. 2008; 129(1):139-47. DOI: 10.1038/jid.2008.203. View

Olsson M, Juhlin L . Long-term follow-up of leucoderma patients treated with transplants of autologous cultured melanocytes, ultrathin epidermal sheets and basal cell layer suspension. Br J Dermatol. 2002; 147(5):893-904. DOI: 10.1046/j.1365-2133.2002.04837.x. View

10.

Verma R, Grewal R, Chatterjee M, Pragasam V, Vasudevan B, Mitra D . A comparative study of efficacy of cultured versus non cultured melanocyte transfer in the management of stable vitiligo. Med J Armed Forces India. 2014; 70(1):26-31. PMC: 3946421. DOI: 10.1016/j.mjafi.2013.09.004. View

11.

Herlyn M, Rodeck U, Mancianti M, Cardillo F, Lang A, Ross A . Expression of melanoma-associated antigens in rapidly dividing human melanocytes in culture. Cancer Res. 1987; 47(12):3057-61. View

12.

Arita Y, ODriscoll K, Weinstein I . Growth of human melanocyte cultures supported by 12-O-tetradecanoylphorbol-13-acetate is mediated through protein kinase C activation. Cancer Res. 1992; 52(16):4514-21. View

13.

Hu F, STARICCO R, Pinkus H, FOSNAUGH R . Human melanocytes in tissue culture. J Invest Dermatol. 1957; 28(1):15-32. DOI: 10.1038/jid.1957.3. View

14.

Shahbazi A, Abedi Valugerdi M, Kazemi S, Samadi Kochaksaraei S, Naseh M, Aghdami N . Safety and Efficacy of Autologous Melanocyte/Keratinocyte Transplantation in Patients with Refractory Stable Vitiligo. Dermatology. 2023; 239(6):919-925. DOI: 10.1159/000533353. View

15.

Jule S, Bosse P, Egidy G, Panthier J . Establishment and characterization of a normal melanocyte cell line derived from pig skin. Pigment Cell Res. 2003; 16(4):407-10. DOI: 10.1034/j.1600-0749.2003.00071.x. View

16.

Godwin L, Castle J, Kohli J, Goff P, Cairney C, Keith W . Isolation, culture, and transfection of melanocytes. Curr Protoc Cell Biol. 2014; 63:1.8.1-20. DOI: 10.1002/0471143030.cb0108s63. View

17.

Wajapeyee N, Serra R, Zhu X, Mahalingam M, Green M . Oncogenic BRAF induces senescence and apoptosis through pathways mediated by the secreted protein IGFBP7. Cell. 2008; 132(3):363-74. PMC: 2266096. DOI: 10.1016/j.cell.2007.12.032. View

18.

Czajkowski R, Pokrywczynska M, Placek W, Zegarska B, Tadrowski T, Drewa T . Transplantation of cultured autologous melanocytes: hope or danger?. Cell Transplant. 2010; 19(5):639-43. DOI: 10.3727/096368910X491798. View

19.

Ramos M, Ramos D, Gontijo G, Ramos C, Rocha T, Rocha R . Non-cultured melanocyte/keratinocyte transplantation for the treatment of stable vitiligo on the face: report of two cases. An Bras Dermatol. 2013; 88(5):811-3. PMC: 3798362. DOI: 10.1590/abd1806-4841.20132054. View

20.

Boyce S, Zimmerman R, Supp D . Tumorigenicity Testing in Athymic Mice of Cultured Human Melanocytes for Transplantation in Engineered Skin Substitutes. Cell Transplant. 2014; 24(8):1423-9. DOI: 10.3727/096368914X683052. View